Rosetta Genomics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ROSGQ and buy or sell other stocks, ETFs, and their options commission-free!

About ROSGQ

Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. 

CEO
Ken Berlin
CEOKen Berlin
Employees
86
Employees86
Headquarters
Rehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded
2000
Founded2000
Employees
86
Employees86

ROSGQ Key Statistics

Market cap
593.00
Market cap593.00
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
279.60
Average volume279.60
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0002
52 Week high$0.0002
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, Rosetta Genomics(ROSGQ) shares are valued at $0.00. The company's market cap stands at 593.

On 2026-03-16, Rosetta Genomics(ROSGQ) stock opened at —, reached a high of —, and a low of —.

The Rosetta Genomics(ROSGQ)'s current trading volume is 0, compared to an average daily volume of 279.6.

During the past year, Rosetta Genomics(ROSGQ) stock moved between $0.00 at its lowest and $0.00 at its peak.

During the past year, Rosetta Genomics(ROSGQ) stock moved between $0.00 at its lowest and $0.00 at its peak.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.